EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients

Valentina Gutierrez, Joseph Stanek, Monica I Ardura iD, Eunkyung Song iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Valentina Gutierrez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Disease and Host Defense, Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Viral Load, Antiviral Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytomegalovirus (CMV) contributes to morbidity and mortality in allogeneic hematopoietic cell transplantation (allo‐HCT) recipients. Pre‐emptive antiviral therapy (PET) reduces the incidence of CMV end‐organ disease (EOD), though relevant viral thresholds to initiate PET remain undefined. We evaluated the impact of viral loads (VLs) at PET initiation on virologic and clinical outcomes following pediatric allo‐HCT.

Methods

Single‐center retrospective cohort analysis of children who underwent their first allo‐HCT from January 2014 to December 2020. Weekly quantitative plasma CMV polymerase chain reaction was performed until Day +100 and PET was initiated once VL exceeded a pre‐defined threshold per institutional guidelines. Patients were followed for 1‐year post‐HCT to evaluate virologic and clinical outcomes including end‐organ disease (EOD), overall survival (OS), and non‐relapse mortality (NRM).

Results

Among 146 allo‐HCT recipients, CMV DNAemia occurred in 40 patients (27%) at a median of 15 days post‐HCT (interquartile range 6–28.5). Ten percent ( n = 4) had spontaneous resolution of DNAemia, while 90% ( n = 36) required PET. PET initiated when CMV VL was ≥ 1000 IU/mL ( n = 21) vs when VL < 1000 IU/mL ( n = 15) resulted in higher peak CMV VL (12,670 vs. 1284 IU/mL, p = 0.0001) and longer time to CMV DNAemia resolution (36 vs. 24 days, p = 0.035). There were no differences in EOD, OS, or NRM at 12 months post‐HCT based on VL at PET initiation.

Conclusions

Initiating PET when CMV VL was ≥1000 IU/mL resulted in significantly higher peak VL and prolonged DNAemia, with no differences in EOD, OS, or NRM at 12 months post pediatric HCT. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCytomegalovirus InfectionsViral LoadAntiviral AgentsCytomegalovirusTransplantation, HomologousHumansRetrospective StudiesMaleChildFemaleChild, PreschoolAdolescentInfantDNA, Viral

Stichwörter der Autor:innen

cytomegalovirus DNAemiapediatric allogeneic transplantationpreemptive antiviral therapyviral threshold

Substanzen

Antiviral AgentsDNA, Viral

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Infectious Disease and Host Defense, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Division of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.

ORCID-Profile: Monica I Ardura, Eunkyung Song

Zitieren

APA

Gutierrez, V., Stanek, J., Ardura, M. I., & Song, E. (2024). Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14358

Vancouver

Gutierrez V, Stanek J, Ardura MI, Song E. Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients. Transplant Infectious Disease. 2024. doi:10.1111/tid.14358

BibTeX
@article{Gutierrez2024,
  author = {Gutierrez, Valentina and Stanek, Joseph and Ardura, Monica I and Song, Eunkyung},
  title = {Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14358}
}
Kostenlos starten →